Skip to main content
Funded Studies

Role of Inflammation in Parkinson's Disease

We hypothesize that the inflammatory protein galectin-3 contributes to PD progression.

Study Design:
We will use pre-clinical models that lack galectin-3 to evaluate inflammation, neuronal cell death and behavior. First, we will test the effect of a toxin called MPTP to produce PD pathology. Next, we will inject a special virus to make brain cells produce the protein alpha-synuclein.

Impact on Diagnosis/Treatment of Parkinson's Disease:
This research project will show us how to reduce inflammation in the brain and protect cells by targeting galectin-3 in pre-clinical models of PD, thereby increasing the chance to move toward clinical trials.

Next Steps for Development:
The next step will be to use specific inhibitors of galectin-3 to test if they are effective as neuroprotective treatments in pre-clinical models of PD.


Discover More Grants

Search by Related Keywords

Within the Same Program

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.